Back to Newsroom

Arbutus to Host Live Webinar on Developments of LNP Delivery for mRNA-based Therapeutics

VANCOUVER, British Columbia and WARMINSTER, Pa., Sept. 07, 2017 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation(Nasdaq:ABUS), an industry-leading hepatitis B virus (HBV) therapeutic solutions company, announced today that it will host a live,
READ MORE…